The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share. The biopharmaceutical company posted ...
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a ...
Veralto Corporation (VLTO), headquartered in Waltham, Massachusetts, offers water analytics, water treatment, marking and coding, and packaging and color services. Valued at $24.2 billion by market ...
Repligen expects full-year earnings in the range of $1.67 to $1.76 per share, with revenue in the range of $685 million to $710 million. This story was generated by Automated Insights ( ...
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Ardelyx Inc. (ARDX) on Thursday reported fourth-quarter net income of $4.6 million, after reporting a loss in the same period a year earlier. The Waltham, ...
Major Wall Street banks are reportedly scrubbing DEI verbiage from their websites in the latest industry retreat since Donald Trump took office and took aim at corporate wokeness. JPMorgan Chase ...
A pedestrian crash in Grafton, Massachusetts, has shut down a street for several hours while police investigate, the town's police department said. The crash happened Monday afternoon on Worcester ...
Does this famous investor know something Wall Street doesn't? Let's find out. Friday was a big day for investors and the stock market in general as it offered them a glimpse into the latest moves ...
Companies in the S&P 500 appear increasingly focused on tariff policies under President Donald Trump, a point of potential volatility for the U.S. stock market, according to a research note from ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device industries. He has written about Covid-19 vaccines, advances in cancer ...
Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, Massachusetts, offers life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services ...
The Waltham, Massachusetts-based company said it had net income of $1 per share. Earnings, adjusted for one-time gains and costs, came to $1.20 per share. The results matched Wall Street expectations.